Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-08 5:24 pm Unchanged |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Novartis Institutes for BioMedical Research Inc. | 3,948,482 9.710% |
0 (Unchanged) |
Filing History |
| 2021-02-02 1:03 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Atlas Venture Fund IX L.P. | 2,945,453 7.240% |
-1,709,000 (-36.72%) |
Filing History |
| 2020-12-10 09:15 am Purchase |
2020-12-09 | 13G | Surface Oncology, Inc. SURF |
FMR CORP | 2,048,321 5.035% |
750,038 (+57.77%) |
Filing History |
| 2020-05-29 5:06 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
BIOTECHNOLOGY VALUE FUND L P | 2,125,650 5.800% |
2,125,650 (New Position) |
Filing History |
| 2020-05-29 4:13 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
EcoR1 Capital LLC | 5,033,861 12.800% |
3,732,148 (+286.71%) |
Filing History |
| 2020-05-29 4:05 pm Purchase |
2020-05-19 | 13G | Surface Oncology, Inc. SURF |
Venrock Healthcare Capital Partners II, L.P. | 3,877,895 9.900% |
3,877,895 (New Position) |
Filing History |